Plasma Cells Institutesp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-11-30
Share capital
10,000.00 PLN
Registered address
Sprzymierzeńców 16, 58-100 Świdnica, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2022 – the filing deadline has passed. 1 of 4 financial statements was filed late (for 2021, 97 days late).

  • 2022not filed
  • 202120/10/2022
  • 202017/09/2021
  • 201913/05/2020
  • 201808/05/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2021.

Results vs industry

Revenue
This companyUSD 41.50kMedianUSD 178.92kAverageUSD 6.85m
Net profit
This companyUSD -52.54kMedianUSD 2.73kAverageUSD 464.86k
Operating costs
This companyUSD 93.65kMedianUSD 175.18kAverageUSD 6.09m
Assets
This companyUSD 54.44kMedianUSD 160.35kAverageUSD 5.64m

Authorized Representatives

Agata Edyta Kępa – President of the Management Board
Andrzej Szymon Kępa – Attorney-in-fact

Manner of representation

To submit declarations of will on behalf of the company concerning disposing of a right or incurring an obligation to render a performance with a value not exceeding PLN 50,000, the President of the Management Board acting independently or two members of the management board jointly are authorised.

Ownership

OwnerSharesShare valueStake
Agata Edyta Kępa
45$1,215.5645%
Robert Waldemar Kubaśage 47
55$1,485.6855%

Beneficial owners

Person

Subsidiaries

NameStake
HILO Pharmasp. z o.o.
33.3333%

Bank accounts

Was a VAT taxpayer from 2012-01-01 to 2025-03-28.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $12,723.

PurposeGross amount
Other crisis aid
$1,651
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$280
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
Glantiersp. z o.o.
IDO Labsp. z o.o.
Skorasp. z o.o.
Reve De Chantellesp. z o.o.
Farmacia Verdesp. z o.o.
Lupharm Laboratorysp. z o.o.
AJKsp. z o.o.
InornaP.S.A.
Kabos Cosmeticssp. z o.o.
BY Corelsp. z o.o.

FAQ

Last updated: 2026-04-21